Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
11/28/2002 | CA2446324A1 Quinoline derivatives as ligands for the neuropeptide y receptor |
11/28/2002 | CA2446316A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
11/28/2002 | CA2446313A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
11/28/2002 | CA2446311A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
11/28/2002 | CA2446155A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
11/28/2002 | CA2446154A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
11/28/2002 | CA2427619A1 Pharmaceutically active isoindoline derivatives |
11/28/2002 | CA2410391A1 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts |
11/27/2002 | EP1260512A1 Novel cyclic amide derivatives |
11/27/2002 | EP1260511A1 Process for the preparation of 5-chloro-1-(4-fluorophenyl)-3-(1,2,3,6-tetrahydropyridin-4-yl)indole and method of manufacturing sertindole |
11/27/2002 | EP1260504A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives |
11/27/2002 | EP1260223A1 Taxanes having furyl or thienyl substituted side-chain |
11/27/2002 | EP1259588A2 Composition and method for bleaching a substrate |
11/27/2002 | EP1259522A1 Ligand and complex for catalytically bleaching a substrate |
11/27/2002 | EP1259506A1 Pyrazinone thrombin inhibitors |
11/27/2002 | EP1259505A2 Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same |
11/27/2002 | EP1259504A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
11/27/2002 | EP1259491A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates and amides and their use as alpha-1a agonists |
11/27/2002 | EP1259489A1 Aryl fused azapolycyclic compounds |
11/27/2002 | EP1259487A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
11/27/2002 | EP1259485A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
11/27/2002 | EP1259242A2 Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy |
11/27/2002 | EP1001934B1 Indole compounds as cox-2 inhibitors |
11/27/2002 | EP1000035B1 Substituted 6-phenylphenanthridines |
11/27/2002 | EP0983246B1 Synthesis of acridine derivative multidrug-resistant inhibitors |
11/27/2002 | EP0929547B1 Benzamidine derivatives substituted by cyclic amino acid or cycl ic hydroxy acid derivatives and their use as anti-coagulants |
11/27/2002 | EP0912554B1 Indoline derivatives useful as 5-ht-2c receptor antagonists |
11/27/2002 | EP0844825B1 Insecticidal n-(substituted arylmethyl)-4- bis(substituted phenyl or pyridyl)methyl]piperidines |
11/27/2002 | CN1382140A Neurotrophic pyrrolidines and piperidines and related compositions containing them |
11/27/2002 | CN1382138A Piperidine derivatives as reuptake inhibitors |
11/27/2002 | CN1382136A N-heterocyclic derivatives as NOS inhibitors |
11/27/2002 | CN1382135A Amine and amide derivatives as ligands for neuropeptide YY5 receptor usefu in treatment of obesity and other disorders |
11/27/2002 | CN1382125A Bicycle vasporession agonists |
11/27/2002 | CN1382124A Bicycle androgen and progesterone receptor modulator compounds and methods |
11/27/2002 | CN1382049A Method for stabilizing benzimidazole compounds |
11/27/2002 | CN1382044A Use of cell factor inhibiting anti-inflammatory agent in rhinovirus infection |
11/27/2002 | CN1094942C Propiophenone derivatives and process for preparing the same |
11/27/2002 | CN1094939C Microbiocidal benzotriazoles compounds, making method and use |
11/27/2002 | CN1094938C Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl group as stabilizer for organic materials |
11/27/2002 | CN1094937C Farnesyltransferase inhibiting quinazolinones |
11/27/2002 | CN1094928C 1-arylpyrazoles derivative, its preparation method and use |
11/27/2002 | CN1094926C Antimer pure acetacetates, its preparation method and use |
11/27/2002 | CN1094725C N-aryl-1,2,4-triazolin-5-ones |
11/26/2002 | US6486191 Fungicidal activity |
11/26/2002 | US6486187 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
11/26/2002 | US6486182 Mutual prodrugs of amlodipine and atorvastatin |
11/26/2002 | US6486180 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
11/26/2002 | US6486174 Treatment of tumor growth, metastasis, restenosis, osteoporosis, inflammation, macular degeneration, diabetic retinopathy, rheumatoid arthritis, sickle cell anemia, nerve system disorders |
11/26/2002 | US6486173 Serotonin-7 (5-ht7); treatment of central nervous system disorders such as sleep disorders, depression and schizophrenia; for example 1,3-dihydro-2-((4-(4-fluorophenyl)-4-oxobutyl))isoindole |
11/26/2002 | US6486154 (Hetero) aryl-sulfonamide derivatives, their preparation and their use as factor XA inhibitors |
11/26/2002 | US6486153 Phenylindole derivatives as 5-HT2A receptor ligands |
11/26/2002 | US6486151 N-oxides of heterocyclic esters, amides, thioesters, and ketones |
11/26/2002 | CA2093203C Pyrimidine derivatives and processes for the preparation thereof |
11/26/2002 | CA1341402C Chemiluminescent acridine derivatives and their use in luminescence immunoassays |
11/22/2002 | WO2001090079A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists |
11/22/2002 | CA2410304A1 Novel carbamates and ureas production and use thereof as endothelin receptor antagonists |
11/21/2002 | WO2002093164A2 Pyridylpyrimidine derivatives as effective compounds against prion diseases |
11/21/2002 | WO2002092611A1 Polymerisation catalyst |
11/21/2002 | WO2002092602A2 PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-[2,3-f] QUINOLINE |
11/21/2002 | WO2002092593A1 4-(4-pyridazinyl)pyrazole derivatives |
11/21/2002 | WO2002092592A1 Novel 1-amidomethylcarbonyl-piperidine derivatives, method and intermediate products for the production thereof and medicament containing said compounds |
11/21/2002 | WO2002092588A2 Aromatic sulfone hydroxamates and their use as protease inhibitors |
11/21/2002 | WO2002092585A1 Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders |
11/21/2002 | WO2002092578A1 Quinazoline derivatives |
11/21/2002 | WO2002092577A1 Quinazoline derivatives |
11/21/2002 | WO2002092576A1 Diarylurea derivatives useful as anti-inflammatory agents |
11/21/2002 | WO2002092575A1 Benzimidazole compounds and antiviral uses thereof |
11/21/2002 | WO2002092573A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
11/21/2002 | WO2002092571A1 Novel 4-anilinoquinoline-3-carboxamides |
11/21/2002 | WO2002092565A2 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists |
11/21/2002 | WO2002092563A2 Protease inhibitors |
11/21/2002 | WO2002092096A1 Antitumor agents |
11/21/2002 | WO2002092090A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
11/21/2002 | WO2002092065A2 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors |
11/21/2002 | WO2002091988A2 Novel processes for the preparation of adenosine compounds and intermediates thereto |
11/21/2002 | WO2002091830A1 Pyridinyl fused bicyclic amide as fungicides |
11/21/2002 | WO2002081728A3 Quinoline inhibitors of hyak1 and hyak3 kinases |
11/21/2002 | WO2002070513A9 Methods for the preparation of mirtazapine intermediates |
11/21/2002 | WO2002062290A3 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
11/21/2002 | WO2002055514A3 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
11/21/2002 | WO2002053528A8 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
11/21/2002 | WO2002028841B1 Reagents for labeling biomolecules having aldehyde or ketone moieties |
11/21/2002 | WO2002022598A8 Quinolinone derivatives as tyrosine kinase inhibitors |
11/21/2002 | US20020173659 Indole derivatives for the treatment of osteoporosis |
11/21/2002 | US20020173658 Administering to a mammal a substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines to reduce the levels of tumor necrosis factor-alpha to treat autoimmune diseases |
11/21/2002 | US20020173656 Guanidine and amidine derivatives as factor Xa inhibitors |
11/21/2002 | US20020173654 Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor, and useful as viricides and antitumor agents |
11/21/2002 | US20020173646 Quinazoline derivatives and pharmaceutical compositions containing them |
11/21/2002 | US20020173529 Fungicide active substance combinations |
11/21/2002 | US20020173527 Tumor necrosis factor antagonist; antiinflammatory agents |
11/21/2002 | US20020173518 Anticoagulant in mammls |
11/21/2002 | US20020173506 Substituted bicyclic heteroaryl compounds and their use as integrin antagonists |
11/21/2002 | US20020173501 Microbiocides |
11/21/2002 | US20020173488 Boronic Ester and acid compounds, synthesis and uses |
11/21/2002 | US20020173469 Protease inhibitors |
11/21/2002 | US20020173468 Modified cytostatic agents |
11/21/2002 | US20020173425 Herbicides |
11/21/2002 | US20020170125 Bridged diaminopyrazole compounds and dye compositions containing same |
11/21/2002 | DE10125295A1 New cyanoanthranylamide derivatives, useful for treating e.g. psoriasis and Kaposi sarcoma, are inhibitors of angiogenesis, acting selectively on specific tyrosine kinases |
11/21/2002 | DE10125294A1 New heterocyclylmethyl-substituted anthranilamide derivatives and analogs as KDR/FLT tyrosine kinase inhibitors, used for treating e.g. psoriasis, restenosis, leukemia, arthritis, eye or kidney disease or arteriosclerosis |